CVS Health Bond ETF Holdings Across Five Treasuries in Q1

60 sourcesUpdated Jul 25, 20261 min read

0

Sponsored

CVS Health expanded its bond ETF exposure in the first quarter by taking new positions across multiple funds. The company acquired 182,800 shares of iShares 3-7 Year Treasury Bond ETF (IEI), valued at about $21.68 million, making IEI roughly 10% of CVS’s portfolio and its second-largest holding. It also opened a stake in Vanguard Short-Term Corporate Bond ETF (VCSH) of 120,000 shares worth about $9.51 million, roughly 4.5% of CVS’s portfolio and its eighth-largest position. In addition, CVS purchased 20,000 shares of iShares 20+ Year Treasury Bond ETF (TLT) for about $1.73 million, representing 0.8% of the portfolio and ranking around 18th in size. The retailer also added 60,000 shares of Vanguard Intermediate-Term Corporate Bond ETF (VCIT) worth about $4.97 million, about 2.3% of holdings and 12th largest, and 35,000 shares of iShares 7-10 Year Treasury Bond ETF (IEF) for roughly $3.34 million, about 1.6% of the portfolio and 16th largest.

Sponsored

In this story:

Sponsored

How it spread

Broke baseballnewssource.com · Jul 24, 1:01 AM ET

More on this story

Back to News

World

Pope Leo XIV Visits Argentina Amid Milei Tensions

Pope Leo XIV’s visit to Argentina—the first papal visit since 1987—is drawing attention to his ideological divide with President Javier Milei, whose austerity policies the Catholic Church says have harmed the poor. Leo’s first stop at a home for people with disabilities underscores the dispute: the facility says government cuts have halted supplies of medication, special food and diapers.

123 sources

Business

130 sources +27h on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

Anthropic IPO Valuation Could Reach $1.5 Trillion

Anthropic’s planned IPO is facing mounting uncertainty as investors reportedly push to lower its expected valuation from roughly $1.4 trillion–$1.5 trillion, with estimates ranging toward $1 trillion to $1.3 trillion amid a sell-off in AI stocks. Prediction-market odds for a near-term listing have also fallen, and reports say the company could reduce the offering or delay it.

402 sources

Sponsored

Finance

CoreWeave Raises Outlook as Debt and Spending Mount

CoreWeave’s third-quarter revenue topped expectations, its backlog reached about $133 billion, and the AI cloud provider raised its full-year revenue outlook to $13 billion–$13.3 billion. Shares rose in after-hours trading, though investors remain focused on the company’s debt and rising interest costs as it expands capacity.

155 sources